查看購物車
  • English
封面
市場調查報告書
商品編碼
1912827

真空採血管市場：按產品類型、採血系統、添加劑、容量、應用和最終用戶分類－2026-2032年全球預測

Vacutainer Blood Collection Tube Market by Product Type, Blood Collection System, Additive, Volume, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年真空採血管市場價值為 16.4 億美元，預計到 2026 年將成長至 17.4 億美元，年複合成長率為 6.75%，到 2032 年將達到 26 億美元。

關鍵市場統計數據
基準年 2025 16.4億美元
預計年份：2026年 17.4億美元
預測年份 2032 26億美元
複合年成長率 (%) 6.75%

一份策略性主管概述，涵蓋了影響真空採血管產業的基本促進因素、臨床意義、材料創新和採購考量。

本執行摘要為採購主管、臨床實驗室主任、生產負責人和投資者提供了一份簡潔專業的Vacutainer採血管市場概覽。它整合了市場動態、材料和設計趨勢、供應鏈脆弱性以及臨床應用促進因素，同時保持了決策者所需的實用性。摘要重點強調了材料選擇、系統人體工學、輔料相容性和最終用戶工作流程等影響採購和產品開發決策的核心因素。

識別關鍵的轉型轉變，這些轉變正在重新定義真空採血管市場的產品設計、供應鏈韌性、添加劑標準化以及對臨床工作流程的影響。

真空採血管生態系統正經歷多重變革，這些變革正在改變產品設計、籌資策略和臨床實踐。材料創新是其核心，玻璃和先進塑膠之間的過渡反映了檢體完整性、破損風險和成本效益之間相互衝突的考慮。同時，真空密封技術和管蓋系統的改進降低了溶血率，提高了高靈敏度檢測的檢體穩定性，從而影響了臨床醫生和檢查室的選擇。

分析2025年美國關稅調整對真空包裝產品籌資策略、生產基地、採購行為及供應鏈韌性的累積影響

2025年美國生效的關稅調整將對真空包裝供應鏈上的所有相關人員產生複雜而多方面的影響。關稅變化可能會增加進口原料和成品的到岸成本，促使採購團隊重新評估總擁有成本並探索替代籌資策略。如果進口關稅影響到玻璃組件、聚合物樹脂或輔助包裝材料，製造商可能會轉移生產地點或重新談判供應商契約，以保持競爭力並維持品質標準。

全面的細分分析揭示了產品類型、採血系統、輔料化學成分、臨床應用、終端用戶需求和試管容量如何影響需求和採購決策。

詳細的細分分析揭示了產品類型、採集系統、賦形劑、應用、最終用戶和銷售等因素對需求促進因素的細微差別，從而指南產品策略和市場推廣策略。就產品類型而言，在化學惰性和高溫滅菌是優先考慮因素的場合，玻璃仍然是首選；但塑膠因其抗碎裂性、輕便性和擴充性的生產方式而日益普及。就採集系統而言，蝶形針對於困難採血和兒童護理至關重要；注射器用於某些床邊和介入醫學場景；而真空採血管因其高效性和與自動化處理的兼容性，在常規檢查室工作流程中佔據主導地位。

區域洞察：美洲、歐洲、中東和非洲以及亞太地區對真空採血管產品製造地選擇、監管協調和分銷策略的影響

區域趨勢將在決定真空採血管產品的製造地、監管路徑和分銷策略方面發揮關鍵作用。在美洲，大規模綜合醫療保健網路、完善的血庫基礎設施和先進的實驗室自動化技術影響市場需求，供應商則專注於規模、文件和服務協議。歐洲、中東和非洲地區的情況則呈現出多樣性：在歐洲部分地區，嚴格的管理體制和對可追溯性的重視推動了合規性投資，而中東和北非地區的市場則在物流能力波動的情況下，優先考慮可靠且經濟高效的供應。

關鍵公司和競爭考察，概述了真空採血管市場領導者與挑戰者在創新、製造地、監管嚴格程度和策略夥伴關係關係方面的差異。

競爭格局呈現出成熟製造商、專業利基生產商和契約製造製造商並存的局面，它們都在推動創新、規模化和分銷。市場領導往往透過投資材料科學、高通量生產和完善的品質系統來脫穎而出，這些系統能夠支持全球監管申報。專業公司則經常推出針對特定臨床領域或高價值終端用戶的創新產品，例如低溶血性瓶蓋、用於新型檢測的賦形劑最佳化以及符合人體工學的採血系統，從而展開競爭。

針對製造商、經銷商和負責人的具體策略建議：加強創新通路建設、實現採購多元化以及加強臨床和商業合作

為了獲得永續的競爭優勢，產業領導者應採取多管齊下的策略，平衡材料創新、供應鏈韌性以及與臨床工作流程的緊密結合。優先進行材料和輔料的研發，以證明其能夠提高檢體完整性並降低分析前變異性，並在臨床化學和血液學等常見臨床應用中檢驗這些改進。同時，應實現生產和採購多元化，並引入區域合作夥伴，以降低關稅相關風險，並在不斷變化的貿易環境中縮短補貨週期。

本文概述了透明嚴謹的調查方法，描述了關鍵相關人員的參與、二次檢驗、數據三角測量以及分析中應用的品管措施。

分析採用混合研究方法，結合了實驗室主任、採購人員、生產工程師和臨床科學家的訪談，以及對監管文件、生產標準和產品文獻的全面二次檢驗。一手研究包括結構化訪談和專題研討會，旨在揭示採購挑戰、輔料偏好和自動化相容性問題。二級資訊來源則用於檢驗監管路徑、材料性能聲明和已發布的生產規範指南。

綜合策略要務，協調真空包裝領域的材料創新、供應鏈敏捷性、監管準備和終端用戶合作。

總之，真空採血管生態系統處於不斷發展的材料科學、供應鏈策略和臨床實踐的交匯點。製造商和採購商必須在應對不斷變化的貿易政策、不同的區域法規和不斷演進的臨床工作流程的同時，維護患者檢體的完整性和可追溯性。策略重點包括投資於賦形劑和密封件的創新，以減少分析前變異性；實現採購來源多元化，以增強應對關稅和物流中斷的能力；以及加強與終端用戶的合作，以確保與自動化分析平台的兼容性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 真空採血管市場依產品類型分類

  • 玻璃
  • 由塑膠製成

9. 真空採血管市場（依採血系統分類）

  • 蝴蝶
  • 注射器
  • 真空管

第10章 添加劑在真空採血管市場的應用

  • 檸檬酸鹽
  • EDTA
    • K2 EDTA
    • K3 EDTA
  • 肝素
  • 不含添加劑

第11章 真空採血管市場（依容量分類）

  • 2 ml
  • 4 ml
  • 6 ml

第12章 真空採血管市場：依應用領域分類

  • 臨床化學
  • 血液學
  • 免疫學
  • 微生物學

第13章 真空採血管市場（依最終用戶分類）

  • 血庫
  • 診斷檢查室
  • 醫院
  • 研究中心

第14章 各地區真空採血管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 真空採血管市場（依集團分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國真空採血管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章美國真空採血管市場

第18章 中國真空採血管市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma
  • Becton, Dickinson and Company
  • Biosigma Srl
  • Cardinal Health
  • FL Medical Srl
  • Greiner Bio-One International GmbH
  • Improve Medical Technology Co., Ltd.
  • KABE LABORTECHNIK GmbH
  • Narang Medical Limited
  • Nipro Corporation
  • QIAGEN NV
  • Sarstedt AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13AC2

The Vacutainer Blood Collection Tube Market was valued at USD 1.64 billion in 2025 and is projected to grow to USD 1.74 billion in 2026, with a CAGR of 6.75%, reaching USD 2.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.64 billion
Estimated Year [2026] USD 1.74 billion
Forecast Year [2032] USD 2.60 billion
CAGR (%) 6.75%

Strategic executive overview capturing fundamental drivers, clinical implications, material innovations, and procurement considerations shaping the vacutainer sector

This executive summary presents a concise, expert perspective on the vacutainer blood collection tube landscape intended for procurement leaders, clinical laboratory directors, manufacturing strategists, and investors. It synthesizes market dynamics, material and design trends, supply chain sensitivities, and clinical adoption drivers while preserving actionable clarity for decision makers. The narrative emphasizes material selection, system ergonomics, additive compatibility, and end-user workflows as core vectors that shape procurement and product development choices.

Across clinical settings, the vacutainer remains a foundational consumable that connects preanalytics to downstream diagnostic accuracy. Recent developments in polymer science, single-use ergonomics, and additive standardization have elevated product differentiation while regulatory scrutiny on contamination control and traceability has intensified. This introduction frames the subsequent sections by establishing the underlying forces-innovation, regulation, and procurement economics-that will determine near-term strategic priorities for manufacturers, distributors, and large institutional buyers.

Identifying the key transformative shifts redefining product design, supply chain resilience, additive standardization, and clinical workflow implications across the vacutainer market

The vacutainer ecosystem is undergoing several transformative shifts that are altering product design, sourcing strategies, and clinical practice. Materials innovation is a central axis: the migration between glass and advanced plastics reflects competing priorities of sample integrity, breakage risk, and cost efficiency. At the same time, improvements in vacuum sealing technology and tube closure systems have reduced hemolysis rates and enhanced sample stability for sensitive assays, which in turn affects clinician and laboratory preferences.

Supply chain architecture is shifting toward resilience and regionalization as procurement teams seek to mitigate single-source dependencies and transportation disruptions. Parallel to this, additive formulations and standardization efforts are realigning laboratory workflows; the prominence of anticoagulants such as EDTA in its different salt forms and the use of heparin or citrate are driving compatibility requirements across analytical platforms. Clinical practice changes, including point-of-care testing and decentralized sample collection, are also influencing demand profiles for volumes and device ergonomics. Together, these shifts require manufacturers and buyers to balance innovation with operational reliability and regulatory compliance.

Analyzing the cumulative impact of United States tariff adjustments in 2025 on sourcing strategies, production footprints, procurement behavior, and supply chain resilience for vacutainer products

The introduction of tariff adjustments in the United States in 2025 has complex, multi-faceted implications for stakeholders across the vacutainer supply chain. Tariff changes tend to increase landed costs for imported raw materials and finished goods, prompting procurement teams to reassess total cost of ownership and to explore alternative sourcing strategies. When import duties affect glass components, polymer resins, or ancillary packaging, manufacturers may alter production footprints or renegotiate supplier contracts to preserve competitiveness while maintaining quality standards.

Beyond direct cost effects, tariffs influence inventory management and contractual relationships; buyers often expand safety stock and diversify supplier bases to insulate operations from sudden policy shifts, and manufacturers may accelerate nearshoring or partner with regional contract manufacturers to retain market access. Regulatory compliance and customs procedures can introduce additional administrative overhead, elongating lead times and complicating just-in-time replenishment philosophies. Finally, tariffs can serve as a catalyst for innovation in product design and materials substitution as firms pursue lower-tariff inputs or locally sourced alternatives to maintain margin and service levels.

Comprehensive segmentation insights revealing how product type, collection system, additive chemistry, clinical application, end-user needs, and tube volume shape demand and procurement decisions

A granular segmentation analysis reveals nuanced demand drivers across product type, collection system, additive, application, end user, and volume that inform product strategy and go-to-market approaches. In terms of product type, glass continues to be preferred where chemical inertness and high-temperature sterility are prioritized, while plastic variants gain traction for their breakage resistance, weight advantages, and manufacturing scalability. Regarding collection systems, butterfly devices remain important for difficult draws and pediatric care, syringes serve specific bedside or interventional contexts, and vacuum tubes dominate routine laboratory workflows due to their efficiency and compatibility with automated processing.

Additives represent a critical axis of differentiation: citrate supports coagulation testing, EDTA-available as K2 and K3 salts-remains the workhorse for hematology due to its anticoagulant properties, heparin is chosen for specific chemistry panels, and no-additive tubes are deployed when serum separation is required. Application segmentation underscores distinct requirements for clinical chemistry, hematology, immunology, and microbiology, each imposing particular constraints on tube material, additive selection, and sample stability. End-user patterns reveal that blood banks demand high volume and traceability, diagnostic laboratories prioritize automation compatibility, hospitals require versatility across inpatient workflows, and research centers often seek specialized formulations. Volume preferences-commonly 2 ml, 4 ml, and 6 ml-map to specific testing panels, pediatric versus adult sampling, and instrument throughput considerations, shaping SKU portfolios and inventory strategies.

Key regional insights exploring how the Americas, Europe Middle East & Africa, and Asia-Pacific influence manufacturing choices, regulatory alignment, and distribution strategies for vacutainer products

Regional dynamics play a decisive role in shaping manufacturing footprints, regulatory pathways, and distribution strategies for vacutainer products. In the Americas, demand is influenced by large integrated healthcare networks, robust blood banking infrastructures, and advanced clinical laboratory automation, prompting suppliers to focus on scale, documentation, and service agreements. Europe, Middle East & Africa exhibits heterogeneity: stringent regulatory regimes and an emphasis on traceability in parts of Europe drive compliance investments, while markets across the Middle East and Africa prioritize reliability and cost-effective supply amid variable logistics capacities.

Asia-Pacific serves as both a production hub and a rapidly expanding consumption market, driven by growing clinical testing volumes, investments in hospital networks, and regional manufacturing capabilities that lower lead times for neighboring markets. Across regions, regulatory alignment, reimbursement practices, and public health priorities shape procurement cycles and specification requirements. Strategic regional sourcing, localized validation studies, and investments in third-party quality audits can materially improve service levels and reduce time to market for regionally tailored SKUs.

Key corporate and competitive insights outlining how innovation, manufacturing footprint, regulatory rigor, and strategic partnerships differentiate leaders and challengers in the vacutainer market

The competitive landscape is characterized by a mix of established manufacturers, specialized niche producers, and contract manufacturers that collectively drive innovation, scale, and distribution reach. Market leaders tend to differentiate through investments in materials science, high-throughput manufacturing, and robust quality systems that support global regulatory submissions. Specialist firms often compete on targeted innovation-such as low-hemolysis closures, additive optimization for novel assays, or ergonomically designed collection systems-that appeal to specific clinical segments or high-value end users.

Partnerships and strategic alliances between manufacturers and laboratory systems providers accelerate product validation and adoption by ensuring compatibility with automation platforms and assay workflows. At the same time, contract manufacturers and regional players provide flexibility for rapid scale-up and localized production, which helps buyers reduce lead times and comply with regional sourcing preferences. Across the competitive spectrum, compliance with good manufacturing practices, inspection readiness, and robust supply continuity plans remain differentiators that inform purchasing decisions by large laboratories, hospital networks, and public health institutions.

Actionable strategic recommendations for manufacturers, distributors, and purchasers to strengthen innovation pipelines, diversify sourcing, and enhance clinical and commercial alignment

Industry leaders should pursue a multi-pronged strategy that balances material innovation, supply chain resilience, and close alignment with clinical workflows to capture durable competitive advantage. Prioritize material and additive R&D that demonstrably improves sample integrity and reduces preanalytic variability, while validating those improvements across common clinical applications such as clinical chemistry and hematology. Simultaneously, diversify manufacturing and sourcing to include regional partners that can mitigate tariff-related exposure and shorten replenishment cycles under changing trade conditions.

Invest in stronger collaboration with end users-blood banks, diagnostic laboratories, hospitals, and research centers-to co-develop SKUs optimized for automation compatibility, volume demands, and clinical protocols. Strengthen regulatory and quality infrastructures to streamline cross-border approvals and to support rapid product iterations. Finally, use data from post-market surveillance and laboratory feedback loops to refine product specifications and to create compelling value propositions that demonstrate lower total cost of handling, improved sample integrity, and reduced clinical retests.

Transparent and rigorous research methodology overview describing primary stakeholder engagement, secondary validation, data triangulation, and quality control measures applied to the analysis

The analysis draws on a blended research approach that combines primary interviews with laboratory directors, procurement leads, manufacturing engineers, and clinical scientists together with comprehensive secondary validation from regulatory documents, manufacturing standards, and product literature. Primary research included structured interviews and targeted workshops to surface procurement pain points, additive preferences, and automation compatibility issues. Secondary sources were used to validate regulatory pathways, materials performance claims, and publicly available manufacturing practice guidance.

Data triangulation techniques were applied to reconcile qualitative insights with operational metrics and documented product specifications. Quality controls included cross-validation of interview findings across multiple stakeholder groups, versioned documentation of assumptions, and expert peer review to ensure analytical rigor. The methodology emphasized transparency in segmentation definitions and avoided reliance on any single source, ensuring that conclusions reflect a robust synthesis of operational realities and clinical needs.

Concluding synthesis of strategic imperatives that harmonize material innovation, supply chain agility, regulatory readiness, and end-user collaboration in the vacutainer domain

In conclusion, the vacutainer blood collection tube ecosystem sits at the intersection of materials science, supply chain strategy, and clinical practice evolution. Manufacturers and buyers must navigate trade policy shifts, regional regulatory diversity, and changing clinical workflows while preserving the integrity and traceability of patient samples. Strategic priorities include investing in additive and closure innovations that reduce preanalytic variability, diversifying sourcing to improve resilience against tariff and logistics disruptions, and deepening collaboration with end users to ensure compatibility with automated analytical platforms.

Looking forward, organizations that combine technical excellence in tube design with agile manufacturing footprints and strong regulatory capabilities will be best positioned to support evolving clinical workflows and procurement expectations. By focusing on validated performance gains, responsive supply chain models, and targeted engagement with high-value end users, stakeholders can convert uncertainty into opportunities for differentiation and sustained operational reliability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vacutainer Blood Collection Tube Market, by Product Type

  • 8.1. Glass
  • 8.2. Plastic

9. Vacutainer Blood Collection Tube Market, by Blood Collection System

  • 9.1. Butterfly
  • 9.2. Syringe
  • 9.3. Vacuum Tube

10. Vacutainer Blood Collection Tube Market, by Additive

  • 10.1. Citrate
  • 10.2. Edta
    • 10.2.1. K2 Edta
    • 10.2.2. K3 Edta
  • 10.3. Heparin
  • 10.4. No Additive

11. Vacutainer Blood Collection Tube Market, by Volume

  • 11.1. 2 Ml
  • 11.2. 4 Ml
  • 11.3. 6 Ml

12. Vacutainer Blood Collection Tube Market, by Application

  • 12.1. Clinical Chemistry
  • 12.2. Hematology
  • 12.3. Immunology
  • 12.4. Microbiology

13. Vacutainer Blood Collection Tube Market, by End User

  • 13.1. Blood Banks
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals
  • 13.4. Research Centers

14. Vacutainer Blood Collection Tube Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Vacutainer Blood Collection Tube Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Vacutainer Blood Collection Tube Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Vacutainer Blood Collection Tube Market

18. China Vacutainer Blood Collection Tube Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AdvaCare Pharma
  • 19.6. Becton, Dickinson and Company
  • 19.7. Biosigma S.r.l.
  • 19.8. Cardinal Health
  • 19.9. F.L. Medical S.r.l.
  • 19.10. Greiner Bio-One International GmbH
  • 19.11. Improve Medical Technology Co., Ltd.
  • 19.12. KABE LABORTECHNIK GmbH
  • 19.13. Narang Medical Limited
  • 19.14. Nipro Corporation
  • 19.15. QIAGEN N.V.
  • 19.16. Sarstedt AG & Co. KG
  • 19.17. Sekisui Medical Co., Ltd.
  • 19.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 19.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BUTTERFLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BUTTERFLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BUTTERFLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K2 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K2 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K2 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K3 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K3 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K3 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 2 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 2 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 2 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 4 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 4 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 4 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 6 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 6 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 6 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 152. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 154. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 155. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 176. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 178. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 179. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 184. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 186. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 187. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)